Loading…

Microdosimetry in X-ray synchrotron based binary radiation therapy

Abstract Synchrotron light offers new radiation treatment strategies including binary therapies, such as photoactivation therapy (PAT) where the photoelectric interaction in a high-Z material leads to a localized source of high LET particles, e.g. Auger electrons. Microdosimetry is used to assess th...

Full description

Saved in:
Bibliographic Details
Published in:European journal of radiology 2008-12, Vol.68 (3), p.S126-S128
Main Author: Hugtenburg, R.P
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Synchrotron light offers new radiation treatment strategies including binary therapies, such as photoactivation therapy (PAT) where the photoelectric interaction in a high-Z material leads to a localized source of high LET particles, e.g. Auger electrons. Microdosimetry is used to assess the efficacy of mixed field and binary radiation treatments and describes the clustering of radiation damage on the micron scale due to particles of differing type, energy and origin. The modeling of microdosimetric distributions in varying treatment scenarios, however, relies on accurate electron physics at sub-micron dimensions, challenging the capabilities of current Monte Carlo codes. The intercomparison of measured and modeled microdosimetric spectra from monochromatic X-rays therefore provides a test of electron transport algorithms and fundamental cross-section data. Microdosimetric spectra are compared for Monte Carlo calculations based on atomic and molecular models of the solid and gaseous components of the detector and to spectra calculated in a water medium for spherical volumes of 100 and 1000 nm diameter. Radiobiology experiments show substantial variation in the photon radiobiological effect (RBE) for end-points, such as cell death and transformation. The microdosimetric model indicates that, with careful tuning of the synchrotron energy, a radiobiological advantage can be achieved in photoactivation therapies in addition to dose enhancement.
ISSN:0720-048X
1872-7727
DOI:10.1016/j.ejrad.2008.04.056